Dr. Netea-Maier received the MD and PhD titles at the Radboud University Nijmegen, where she is currently working as an endocrinologist and an associate professor in endocrine tumors. During her career, she has focused on the organization of care for patients with endocrine tumors, particularly thyroid carcinoma. She is the chair of the Endocrine Tumor Board at Radboud University Medical Center and the representative of her institution for the subtheme Thyroid in the ERN Rare Endocrine Diseases and ERN Rare Cancers. She is board member of the Dutch Thyroid Research Foundation. She has combined her clinical work in a center of expertise for thyroid tumors with several research projects. Her research interests include the pathogenesis of endocrine tumors and their long-term consequences, focusing on thyroid cancer and pituitary tumors. In 2006 she was visiting scientist at the University of Colorado, Denver, USA, where she used proteomics techniques to identify markers for thyroid malignancy. In the last years her work was dedicated to understanding the role of inflammation in the pathogenesis of thyroid cancer, and its interplay with autophagy for cell survival, proliferation, and dedifferentiation. She received prestigious research grants from the Royal Dutch Cancer Association and participates in several national and international consortia. Her research has led to 100 peer-reviewed publications and several book chapters, of which 16 in absolute top journals.